Latest Breaking News On - Debora barton - Page 2 : comparemela.com

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMonzrm al malkiHeather savelleDebora bartonGavin macbeathAl malkiJoyce allaireDepartment of hematology hematopoietic cell transplantationGlobe newswire tscan therapeutics incLifesci advisorsAmerican society of hematology annual meetingTscan therapeutics incAmerican society of hematologySecurities exchangeTherapeutics presents initial phaseAmerican society

TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition

TScan Therapeutics Announces Upcoming Presentation at the 65th American Society of Hematology Annual Meeting and Exposition
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSan diego convention centerHeather savelleJoyce allaireNina abelowitzMonzrm al malkiJyun wangErica buonomoAasiya matinShrikanta chattopadhyayMonzr al malkiGavin macbeathJim murrayDebora bartonAl malki

TScan Therapeutics, Inc (TCRX) Announces FDA Clearance of Investigational NDA for TSC-203-A0201

TScan Therapeutics, Inc (TCRX) Announces FDA Clearance of Investigational NDA for TSC-203-A0201
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Gavin macbeathJoyce allaireHeather savelleDebora bartonSecurities exchangeTscan therapeutics incLifesci advisorsDrug administrationChief medicalChief executivePrivate securities litigation reform actSecurities exchange actFinancial conditionAnnual reportSci advisors

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-203-A0201 Targeting PRAME

TSC-203-A0201 is TScan’s fourth TCR-T cell product cleared for use in its solid tumor program, designed to enable customized, multiplexed TCR-T cell therapyWALTHAM, Mass., Aug. 29, 2023 TScan.

Heather savelleJoyce allaireGavin macbeathDebora bartonLifesci advisorsSecurities exchangeGlobe newswire tscan therapeutics incTscan therapeutics incDrug administrationChief medicalChief executivePrivate securities litigation reform actSecurities exchange actFinancial conditionAnnual reportSci advisors

Dr Boreham s Crucible: Arovella Therapeutics

Dr Boreham s Crucible: Arovella Therapeutics
fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomWestern australiaDebora bartonElizabeth stonerSuda arovellaImugene oncarlyticsTom duthyPaul hopperRadiopharm theranosticsStephen carterDavid simmondsGary phillipsHarpic flushmaticTim boreham